Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Ultrasound-guided serratus posterior superior intercostal plane (SPSIP) block for shoulder arthroscopy pain

Official title: Postoperative Analgesic Efficacy of Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block in Arthroscopic Shoulder Surgery

Run by Bursa City Hospital · NCT07394673 · Data updated 2026-11-12

This will test whether an ultrasound-guided serratus posterior superior intercostal plane (SPSIP) block reduces pain after arthroscopic shoulder surgery.

More Shoulder Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment80 (estimated)
SponsorBursa City Hospital
Government
Locations1 site (Bursa, Bursa)
StatusRecruiting
StartedFebruary 20, 2026
Main results expectedSeptember 20, 2026
Study endsNovember 20, 2026
Registry record updatedNovember 3, 2026
Trial IDNCT07394673 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults scheduled for elective arthroscopic shoulder surgery under general anesthesia with ASA physical status I–III who can provide informed consent and meet the inclusion/exclusion criteria are ideal candidates.

Probably not a fit

Patients who use anticoagulant or antiplatelet drugs, have bleeding disorders, infection at the block site, allergy to local anesthetics, diabetes, significant renal or hepatic impairment, pregnancy/lactation, or cognitive impairment are excluded and unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study applies an ultrasound-guided serratus posterior superior intercostal plane (SPSIP) block as a regional analgesic technique for patients having arthroscopic shoulder surgery under general anesthesia. Eligible participants receive the SPSIP block in addition to standard perioperative care as part of a multimodal analgesia plan. Postoperative outcomes will be tracked using patient-reported pain scores (NRS), opioid consumption, and usual recovery measures. The study aims to see if adding the SPSIP block improves early postoperative pain control and recovery after shoulder arthroscopy.

Why it matters

Potential benefit: If successful, the SPSIP block could reduce postoperative pain and opioid requirements and improve recovery after arthroscopic shoulder surgery.

How similar studies have gone: The SPSIP block is a novel regional technique described in 2023 with early reports of near-complete sensory blockade of the posterior neck, shoulder, and hemithorax, but clinical outcome data for shoulder arthroscopy remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Classified as American Society of Anesthesiologists (ASA) physical status I-II-III
* Scheduled for elective shoulder arthroscopy surgery
* Surgery performed under general anesthesia
* Provision of written informed consent

Exclusion Criteria:

* Use of anticoagulant or antiplatelet medications
* Presence of bleeding diathesis or coagulation disorders
* Known allergy or hypersensitivity to local anesthetics or opioid medications
* Infection or history of previous surgery at the planned block site
* Alcohol or drug dependence
* Cognitive impairment preventing reliable pain assessment using the NRS
* Pregnancy or lactation
* Diabetes mellitus
* Renal or hepatic impairment

Where it's running

  • Bursa City Hospital
    Bursa, Bursa, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.